Correspondence re: M. Follen et al., a randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
Formelli
Franca
F
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D017313:Fenretinide / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*; D002578:Uterine Cervical Dysplasia / Q000188:drug therapy*
D000970:Antineoplastic Agents; D017313:Fenretinide